Astria Therapeutics
ATXS
ATXS
43 hedge funds and large institutions have $88.8M invested in Astria Therapeutics in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
31.46% more ownership
Funds ownership: 44.03% → 75.49% (+31%)
Holders
43
Holding in Top 10
1
Calls
$130K
Puts
$4K
Top Buyers
| 1 | +$9.04M | |
| 2 | +$8.14M | |
| 3 | +$5.93M | |
| 4 |
TLP
Tri Locum Partners
New York
|
+$5.71M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$4.52M |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$882K | |
| 3 | -$716K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$52.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$26.6K |